Get in touch

Exciting Days at DCAT in New York!

Tiefenbacher Group - A group of seven smiling people in business attire take a selfie on a busy city street. A banner reads, "Tiefenbacher sends greetings from the DCAT." The TIEFENBACHER GROUP logo highlights this family-owned pharmaceutical company.

Our team sends greetings and impressions from the Big Apple!As we approach the final stretch of DCAT Week 2025 in New York, we reflect on an incredibly successful event so far! The Tiefenbacher Group team has had the privilege of engaging in insightful conversations, strengthening partnerships, and showcasing our latest innovations to make pharmaceuticals more […]

Tiefenbacher Group, OnDosis and Star celebrate iF Design Award for OYSTA

Tiefenbacher Group - A digital display showcases Oysta, a patient management tool focused on patient-centric drug development, on a tablet and smartphone. The Tiefenbacher Group and IF Design Award logos highlight ONDOSIS & STAR's award-winning design for Oysta.

We are proud to announce that OYSTA has been honored with the prestigious iF Design Award for its excellence in digital innovation and user-centric design.This award is a testament to our shared vision and collaborative efforts of our partners—global life science company OnDosis AB and global technology consultancy Star—to redefine medication management for ADHD and […]

OYSTA: Launch of new OYSTA website

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

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Launch of new OYSTA websiteWe are happy that we have launched a new web page for OYSTA – an innovative healthcare brand which we have developed together with our partner OnDosis. With OYSTA, we aim to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and […]

TIEFENBACHER GROUP and OnDosis launch the innovative healthcare brand OYSTA®

Tiefenbacher Group - OYSTA logo beside a medical device showing "10 mg" and a smartphone displaying the OYSTA app for mood tracking, dosage management, and health logs—highlighting patient-centric drug development in pharmaceutical healthcare solutions.

TIEFENBACHER GROUP and OnDosis are thrilled to announce the launch of OYSTA®. The new healthcare brand represents the cooperation initiated in September 2020, including the co-development portfolio of innovative products in five indications. OYSTA® aims to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and […]

New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP

Tiefenbacher Group - Two white and teal handheld medical devices with digital displays showing “10 mg,” next to the Tiefenbacher Group and Ondosis logos, highlight advanced pharmaceutical healthcare solutions for finished dosage forms on a white background.

Innovative Healthcare Pharmaceuticals with e-health technology in the ADHD field, rare diseases, and transplantation medicineSwedish Life science company OnDosis and German B2B pharmaceutical company TIEFENBACHER GROUP initiate four new innovative development projects targeting ADHD, rare diseases, and transplantation medicine. The idea is to improve the health and everyday lives of millions of patients by giving […]

Tiefenbacher Group and OnDosis enter a partnership for medicines and digital health

Tiefenbacher Group - Logos of Tiefenbacher Group (blue dots and text) and Ondosis (green and maroon text with a capsule icon) on a white background, representing leaders in patient-centric drug development and pharmaceutical healthcare solutions.

Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration strengthens both companies’ commitment to further develop and commercialize innovative products within individualized treatments and digital health, combining traditional drug-based medicines with digital therapeutics and intelligent dosing. TIEFENBACHER GROUP and OnDosis enter a […]

Get in touch